Beam TherapeuticsInc Stock Buy Hold or Sell Recommendation

BEAM
 Stock
  

USD 44.37  2.45  5.23%   

Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Beam TherapeuticsInc is 'Hold'. Macroaxis provides Beam TherapeuticsInc buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding BEAM positions. The advice algorithm takes into account all of Beam TherapeuticsInc's available fundamental, technical, and predictive indicators you will find on this site.
  
The advice is provided from Beam TherapeuticsInc's buy-and-hold perspective. Continue to Beam TherapeuticsInc Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. We conduct extensive research on individual companies such as Beam TherapeuticsInc and provide practical buy, sell, or hold advice based on selected investing horizon and risk tolerance towards Beam TherapeuticsInc.

Execute Beam TherapeuticsInc Buy or Sell Advice

The Beam TherapeuticsInc recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Beam TherapeuticsInc. Macroaxis does not own or have any residual interests in Beam TherapeuticsInc or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Beam TherapeuticsInc's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Beam TherapeuticsIncBuy Beam TherapeuticsInc
Hold

Volatility

Details

Hype Condition

Details

Current Valuation

Details

Odds of Distress

Details

Economic Sensitivity

Details

Analyst Consensus

Details

Financial Strenth (F Score)

Details

Financial Leverage

Inapplicable
Details

Reporting Quality (M-Score)

Details
For the selected time horizon Beam TherapeuticsInc has a Risk Adjusted Performance of (0.06), Jensen Alpha of (0.37), Total Risk Alpha of (0.47) and Treynor Ratio of (0.11)
Beam TherapeuticsInc advice module can be used to check and cross-verify current investment recommendation provided by analysts analyzing the company's potential to grow using all of fundamental, technical, data market data available at the time. To make sure Beam TherapeuticsInc is not overpriced, please confirm all Beam TherapeuticsInc fundamentals, including its current valuation, price to book, cash and equivalents, as well as the relationship between the shares owned by institutions and gross profit . Given that Beam TherapeuticsInc has a price to book of 4.30 X, we suggest you to validate Beam TherapeuticsInc market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.

Beam TherapeuticsInc Trading Alerts and Improvement Suggestions

Beam TherapeuticsInc generated a negative expected return over the last 90 days
Beam TherapeuticsInc has high historical volatility and very poor performance
The company reported the previous year's revenue of 51.84 M. Net Loss for the year was (370.64 M) with loss before overhead, payroll, taxes, and interest of (180.29 M).
Beam TherapeuticsInc currently holds about 1.09 B in cash with (66.27 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 15.9.
Beam TherapeuticsInc has a poor financial position based on the latest SEC disclosures
Over 87.0% of the company shares are held by institutions such as insurance companies
Latest headline from news.google.com: Beam Therapeutics Enrolls First Patient in BEACON Clinical Trial of BEAM-101 Base Editing Therapy Candidate for the Treatment of Sickle Cell Disease - Yahoo Finance

Beam TherapeuticsInc Returns Distribution Density

The distribution of Beam TherapeuticsInc's historical returns is an attempt to chart the uncertainty of Beam TherapeuticsInc's future price movements. The chart of the probability distribution of Beam TherapeuticsInc stock daily returns describes the distribution of returns around its average expected value. We use Beam TherapeuticsInc price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Beam TherapeuticsInc returns is essential to provide solid investment advice for Beam TherapeuticsInc.
Mean Return-0.22Value At Risk-7.22
Potential Upside7.32Standard Deviation5.05
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Beam TherapeuticsInc historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Beam TherapeuticsInc Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Beam TherapeuticsInc or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Beam TherapeuticsInc's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Beam TherapeuticsInc stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over NYSE Composite
-0.37
β
Beta against NYSE Composite2.06
σ
Overall volatility
5.09
Ir
Information ratio -0.06

Beam TherapeuticsInc Volatility Alert

Beam TherapeuticsInc exhibits very low volatility with skewness of 0.77 and kurtosis of 1.94. However, we advise investors to further study Beam TherapeuticsInc technical indicators to ensure that all market info is available and is reliable. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Beam TherapeuticsInc's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Beam TherapeuticsInc's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Beam TherapeuticsInc Fundamentals Vs Peers

Comparing Beam TherapeuticsInc's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Beam TherapeuticsInc's direct or indirect competition across all of the common fundamentals between Beam TherapeuticsInc and the related equities. This way, we can detect undervalued stocks with similar characteristics as Beam TherapeuticsInc or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Beam TherapeuticsInc's fundamental indicators could also be used in its relative valuation, which is a method of valuing Beam TherapeuticsInc by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Beam TherapeuticsInc to competition
FundamentalsBeam TherapeuticsIncPeer Average
Return On Equity(0.40) %(0.31) %
Return On Asset(0.08) %(0.14) %
Operating Margin(1.72) %(5.51) %
Current Valuation2.38 B16.62 B
Shares Outstanding70.47 M571.82 M
Shares Owned by Insiders1.85 %10.09 %
Shares Owned by Institutions87.06 %39.21 %
Number of Shares Shorted13.01 M4.71 M
Price to Earning37.48 X28.72 X
Price to Book4.30 X9.51 X
Price to Sales35.88 X11.42 X
Revenue51.84 M9.43 B
Gross Profit(180.29 M)27.38 B
EBITDA(363.19 M)3.9 B
Net Income(370.64 M)570.98 M
Cash and Equivalents1.09 B2.7 B
Cash per Share15.90 X5.01 X
Total Debt3.01 M5.32 B
Debt to Equity0.25 %48.70 %
Current Ratio4.64 X2.16 X
Book Value Per Share10.38 X1.93 K
Cash Flow from Operations(66.27 M)971.22 M
Short Ratio13.39 X4.00 X
Earnings Per Share(3.59) X3.12 X
Price to Earnings To Growth(2.30) X4.89 X
Target Price80.08
Number of Employees50718.84 K
Beta1.66-0.15
Market Capitalization3.3 B19.03 B
Total Asset1.47 B29.47 B
Retained Earnings(208.39 M)9.33 B
Working Capital2.18 B1.48 B
Current Asset2.89 B9.34 B
   Beam Therapeutics exotic insider transaction detected [view details]

About Beam TherapeuticsInc Buy or Sell Advice

When is the right time to buy or sell Beam TherapeuticsInc? Buying financial instruments such as Beam TherapeuticsInc Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
 2021 2022 (projected)
Accounts Payable7.47 M6.44 M
Receivables270 M268.42 M

Use Investing Ideas to Build Portfolios

In addition to having Beam TherapeuticsInc in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Cleaning Thematic Idea Now

Cleaning
Cleaning Theme
Compnanies producing and distributing cleaning products, supplies, and accessories. The Cleaning theme has 0 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Cleaning Theme or any other thematic opportunities.
View All  Next Launch
Continue to Beam TherapeuticsInc Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note that the Beam TherapeuticsInc information on this page should be used as a complementary analysis to other Beam TherapeuticsInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Analyst Recommendations module to analyst recommendations and target price estimates broken down by several categories.

Complementary Tools for Beam TherapeuticsInc Stock analysis

When running Beam TherapeuticsInc price analysis, check to measure Beam TherapeuticsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Beam TherapeuticsInc is operating at the current time. Most of Beam TherapeuticsInc's value examination focuses on studying past and present price action to predict the probability of Beam TherapeuticsInc's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Beam TherapeuticsInc's price. Additionally, you may evaluate how the addition of Beam TherapeuticsInc to your portfolios can decrease your overall portfolio volatility.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Is Beam TherapeuticsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Beam TherapeuticsInc. If investors know Beam TherapeuticsInc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Beam TherapeuticsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
3.3 B
Quarterly Revenue Growth YOY
19.71
Return On Assets
(0.08) 
Return On Equity
(0.40) 
The market value of Beam TherapeuticsInc is measured differently than its book value, which is the value of Beam TherapeuticsInc that is recorded on the company's balance sheet. Investors also form their own opinion of Beam TherapeuticsInc's value that differs from its market value or its book value, called intrinsic value, which is Beam TherapeuticsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Beam TherapeuticsInc's market value can be influenced by many factors that don't directly affect Beam TherapeuticsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Beam TherapeuticsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine Beam TherapeuticsInc value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Beam TherapeuticsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.